DNA topoisomerase IIα expression in optic pathway gliomas of childhood
- 31 December 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (3) , 393-400
- https://doi.org/10.1016/s0959-8049(01)00387-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysisActa Neuropathologica, 2000
- Topoisomerase II as a target for anticancer drugs: When enzymes stop being niceProgress in Nucleic Acid Research and Molecular Biology, 2000
- Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.Journal of Neuro-Oncology, 1999
- Treatment of Newly Diagnosed Glioblastoma Multiforme with Carmustine, Cisplatin and Etoposide Followed by Radiotherapy. A Phase II StudyJournal of Neuro-Oncology, 1999
- Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiformeCancer, 1998
- The proliferative potential of the pilocytic astrocytoma: The relation between MIB-1 labeling and clinical and neuro-radiological follow-upJournal of Neuro-Oncology, 1998
- A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomasJournal of Neuro-Oncology, 1998
- Use of MIB-1 (Ki-67) Immunoreactivity in Differentiating Grade II and Grade III GliomasJournal of Neuropathology and Experimental Neurology, 1997
- Brain tumors with symptomatic onset in the first two years of lifeChild's Nervous System, 1994
- DNA Topoisomerases as Anticancer Drug TargetsPublished by Elsevier ,1990